Global Encapsulated iPSC-Derived Islet Cell Therapy Market Growth (Status and Outlook) 2026-2032
The global Encapsulated iPSC-Derived Islet Cell Therapy market size is predicted to grow from US$ 41.09 million in 2025 to US$ 610 million in 2032; it is expected to grow at a CAGR of 47.7% from 2026 to 2032.
Encapsulated iPSC-Derived Islet Cell Therapy is a regenerative medicine approach in which human induced pluripotent stem cell (iPSC)-derived islet-like cells or ?-cell clusters are combined with immune-isolation devices, hydrogel microcapsules, bioprinted scaffolds, or localized immune-tolerance materials before implantation into the body. The therapy is designed to replace the damaged or absent pancreatic islet function in patients with type 1 diabetes and other insulin-dependent forms of diabetes. By sensing blood glucose levels and secreting insulin, glucagon, and other endocrine hormones, these therapies aim to restore physiological glucose regulation. Key product development priorities include cell maturation, endocrine cell purity, dosing strategy, glucose responsiveness, mass transfer performance of encapsulation materials, retrievability, immune protection efficacy, GMP batch consistency, and long-term safety. The overall gross margin is approximately 70%.
Demand for encapsulated iPSC-derived islet cell therapies is primarily driven by the unmet needs of patients with type 1 diabetes who require lifelong insulin therapy, face a high risk of severe hypoglycemia, have limited access to donor islets, and often require immunosuppressive treatment following transplantation. By combining a scalable iPSC-derived cell source with immune-protective encapsulation technologies, these therapies seek to achieve durable glycemic control without lifelong systemic immunosuppression. Their greatest clinical value lies in high-risk type 1 diabetes, brittle diabetes, and as a potential alternative to donor islet transplantation.
Competition is shifting from cell differentiation capability alone toward integrated expertise spanning cell biology, biomaterials, medical devices, and manufacturing processes. Macroencapsulation devices emphasize retrievability and clinical controllability, while hydrogel and microcapsule technologies focus on efficient nutrient and oxygen transport together with localized immune isolation. Bioprinted tissue constructs aim to recreate physiological cellular architecture, improve nutrient supply, and enhance long-term graft functionality after implantation. Key barriers throughout the supply chain include the establishment of clinical-grade iPSC banks, reproducible directed differentiation, biocompatible encapsulation materials, preservation of cell function under hypoxic conditions, and scalable GMP manufacturing systems.
Regional opportunities are primarily concentrated in the United States, Canada, Europe, and Israel, where regenerative medicine translation is advancing rapidly. In the near term, market activity is expected to remain focused on clinical trial supply, technology licensing, co-development partnerships, and manufacturing process validation. Commercial adoption will largely depend on the safety profile of first-generation products, C-peptide restoration, implant durability, device retrievability, and reimbursement acceptance. If encapsulation or immune-evasion strategies can substantially reduce or eliminate the need for immunosuppression, the eligible patient population and commercial potential of this therapeutic approach could expand significantly.
Report Scope
LPI (LP Information)' newest research report, the “Encapsulated iPSC-Derived Islet Cell Therapy Industry Forecast” looks at past sales and reviews total world Encapsulated iPSC-Derived Islet Cell Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Encapsulated iPSC-Derived Islet Cell Therapy sales for 2026 through 2032. With Encapsulated iPSC-Derived Islet Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Encapsulated iPSC-Derived Islet Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Encapsulated iPSC-Derived Islet Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Encapsulated iPSC-Derived Islet Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Encapsulated iPSC-Derived Islet Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Encapsulated iPSC-Derived Islet Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Encapsulated iPSC-Derived Islet Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Encapsulated iPSC-Derived Islet Cell Therapy market by product type, application, key players and key regions and countries.
Encapsulated iPSC-Derived Islet Cell Therapy is a regenerative medicine approach in which human induced pluripotent stem cell (iPSC)-derived islet-like cells or ?-cell clusters are combined with immune-isolation devices, hydrogel microcapsules, bioprinted scaffolds, or localized immune-tolerance materials before implantation into the body. The therapy is designed to replace the damaged or absent pancreatic islet function in patients with type 1 diabetes and other insulin-dependent forms of diabetes. By sensing blood glucose levels and secreting insulin, glucagon, and other endocrine hormones, these therapies aim to restore physiological glucose regulation. Key product development priorities include cell maturation, endocrine cell purity, dosing strategy, glucose responsiveness, mass transfer performance of encapsulation materials, retrievability, immune protection efficacy, GMP batch consistency, and long-term safety. The overall gross margin is approximately 70%.
Demand for encapsulated iPSC-derived islet cell therapies is primarily driven by the unmet needs of patients with type 1 diabetes who require lifelong insulin therapy, face a high risk of severe hypoglycemia, have limited access to donor islets, and often require immunosuppressive treatment following transplantation. By combining a scalable iPSC-derived cell source with immune-protective encapsulation technologies, these therapies seek to achieve durable glycemic control without lifelong systemic immunosuppression. Their greatest clinical value lies in high-risk type 1 diabetes, brittle diabetes, and as a potential alternative to donor islet transplantation.
Competition is shifting from cell differentiation capability alone toward integrated expertise spanning cell biology, biomaterials, medical devices, and manufacturing processes. Macroencapsulation devices emphasize retrievability and clinical controllability, while hydrogel and microcapsule technologies focus on efficient nutrient and oxygen transport together with localized immune isolation. Bioprinted tissue constructs aim to recreate physiological cellular architecture, improve nutrient supply, and enhance long-term graft functionality after implantation. Key barriers throughout the supply chain include the establishment of clinical-grade iPSC banks, reproducible directed differentiation, biocompatible encapsulation materials, preservation of cell function under hypoxic conditions, and scalable GMP manufacturing systems.
Regional opportunities are primarily concentrated in the United States, Canada, Europe, and Israel, where regenerative medicine translation is advancing rapidly. In the near term, market activity is expected to remain focused on clinical trial supply, technology licensing, co-development partnerships, and manufacturing process validation. Commercial adoption will largely depend on the safety profile of first-generation products, C-peptide restoration, implant durability, device retrievability, and reimbursement acceptance. If encapsulation or immune-evasion strategies can substantially reduce or eliminate the need for immunosuppression, the eligible patient population and commercial potential of this therapeutic approach could expand significantly.
Report Scope
LPI (LP Information)' newest research report, the “Encapsulated iPSC-Derived Islet Cell Therapy Industry Forecast” looks at past sales and reviews total world Encapsulated iPSC-Derived Islet Cell Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Encapsulated iPSC-Derived Islet Cell Therapy sales for 2026 through 2032. With Encapsulated iPSC-Derived Islet Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Encapsulated iPSC-Derived Islet Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Encapsulated iPSC-Derived Islet Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Encapsulated iPSC-Derived Islet Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Encapsulated iPSC-Derived Islet Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Encapsulated iPSC-Derived Islet Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Encapsulated iPSC-Derived Islet Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Encapsulated iPSC-Derived Islet Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Macroencapsulation Device Therapy
- Hydrogel Microencapsulation Therapy
- Conformal Coating Encapsulation Therapy
- Bioprinted Encapsulated Tissue Therapy
- Local Immune Tolerance Matrix Therapy
- Other Encapsulation Architectures
Segmentation by Cell Maturity Stage:
- Pancreatic Endoderm Cells
- Immature Endocrine Progenitors
- Beta Cell-Enriched Clusters
- Islet-Like Endocrine Clusters
- Mature Multihormonal Islet Cells
- Other Maturity Stages
Segmentation by Immune Protection Strategy:
- Physical Immune Isolation
- Local Immune Tolerance
- Hypoimmune Gene Editing
- Encapsulation Plus Gene Editing
- Systemic Immunosuppression-Enabled
- Other Immune Strategies
Segmentation by Development Stage:
- Discovery Research
- Preclinical Development
- IND-Enabling Development
- Phase 1/2 Clinical Stage
- Pivotal and Registration Stage
- Discontinued or Legacy Assets
Segmentation by Application:
- Type 1 Diabetes
- Brittle Diabetes
- Insulin-Dependent Type 2 Diabetes
- Post-Pancreatectomy Diabetes
- Islet Replacement Research
- Other Diabetes Indications
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Vertex Pharmaceuticals
- Aspect Biosystems
- Sernova
- Evotec
- Sana Biotechnology
- Kadimastem
- iTolerance
- Seraxis
- CRISPR Therapeutics
- Novo Nordisk
- Eli Lilly
- Sigilon Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size (2021-2032)
2.1.2 Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Encapsulated iPSC-Derived Islet Cell Therapy by Country/Region (2021, 2025 & 2032)
2.2 Encapsulated iPSC-Derived Islet Cell Therapy Segment by Type
2.2.1 Macroencapsulation Device Therapy
2.2.2 Hydrogel Microencapsulation Therapy
2.2.3 Conformal Coating Encapsulation Therapy
2.2.4 Bioprinted Encapsulated Tissue Therapy
2.2.5 Local Immune Tolerance Matrix Therapy
2.2.6 Other Encapsulation Architectures
2.2.7 Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type
2.2.7.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.7.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
2.3 Encapsulated iPSC-Derived Islet Cell Therapy Segment by Cell Maturity Stage
2.3.1 Pancreatic Endoderm Cells
2.3.2 Immature Endocrine Progenitors
2.3.3 Beta Cell-Enriched Clusters
2.3.4 Islet-Like Endocrine Clusters
2.3.5 Mature Multihormonal Islet Cells
2.3.6 Other Maturity Stages
2.3.7 Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage
2.3.7.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Cell Maturity Stage (2021 VS 2025 VS 2032)
2.3.7.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Maturity Stage (2021-2026)
2.4 Encapsulated iPSC-Derived Islet Cell Therapy Segment by Immune Protection Strategy
2.4.1 Physical Immune Isolation
2.4.2 Local Immune Tolerance
2.4.3 Hypoimmune Gene Editing
2.4.4 Encapsulation Plus Gene Editing
2.4.5 Systemic Immunosuppression-Enabled
2.4.6 Other Immune Strategies
2.4.7 Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy
2.4.7.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Immune Protection Strategy (2021 VS 2025 VS 2032)
2.4.7.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2021-2026)
2.5 Encapsulated iPSC-Derived Islet Cell Therapy Segment by Development Stage
2.5.1 Discovery Research
2.5.2 Preclinical Development
2.5.3 IND-Enabling Development
2.5.4 Phase 1/2 Clinical Stage
2.5.5 Pivotal and Registration Stage
2.5.6 Discontinued or Legacy Assets
2.5.7 Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage
2.5.7.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Development Stage (2021 VS 2025 VS 2032)
2.5.7.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Development Stage (2021-2026)
2.6 Encapsulated iPSC-Derived Islet Cell Therapy Segment by Application
2.6.1 Type 1 Diabetes
2.6.2 Brittle Diabetes
2.6.3 Insulin-Dependent Type 2 Diabetes
2.6.4 Post-Pancreatectomy Diabetes
2.6.5 Islet Replacement Research
2.6.6 Other Diabetes Indications
2.6.7 Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application
2.6.7.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.6.7.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
3 ENCAPSULATED IPSC-DERIVED ISLET CELL THERAPY MARKET SIZE BY PLAYER
3.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Player
3.1.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026)
3.1.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ENCAPSULATED IPSC-DERIVED ISLET CELL THERAPY BY REGION
4.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026)
4.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
4.4 APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
4.5 Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026)
5.2 Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
5.3 Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026)
6.2 APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
6.3 APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026)
7.2 Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
7.3 Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy by Region (2021-2026)
8.2 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ENCAPSULATED IPSC-DERIVED ISLET CELL THERAPY MARKET FORECAST
10.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.1.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.1.2 Americas Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.1.3 APAC Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.1.4 Europe Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.1.5 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.2 Americas Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.2.2 Canada Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.2.3 Mexico Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.2.4 Brazil Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.3 APAC Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.3.1 China Encapsulated iPSC-Derived Islet Cell Therapy Market Forecast
10.3.2 Japan Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.3.3 Korea Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.3.4 Southeast Asia Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.3.5 India Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.3.6 Australia Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.4 Europe Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.4.2 France Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.4.3 UK Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.4.4 Italy Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.4.5 Russia Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.5 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.5.2 South Africa Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.5.3 Israel Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.5.4 Turkey Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.6 Global Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Type (2027-2032)
10.7 Global Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Vertex Pharmaceuticals
11.1.1 Vertex Pharmaceuticals Company Information
11.1.2 Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.1.3 Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Vertex Pharmaceuticals Main Business Overview
11.1.5 Vertex Pharmaceuticals Latest Developments
11.2 Aspect Biosystems
11.2.1 Aspect Biosystems Company Information
11.2.2 Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.2.3 Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Aspect Biosystems Main Business Overview
11.2.5 Aspect Biosystems Latest Developments
11.3 Sernova
11.3.1 Sernova Company Information
11.3.2 Sernova Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.3.3 Sernova Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sernova Main Business Overview
11.3.5 Sernova Latest Developments
11.4 Evotec
11.4.1 Evotec Company Information
11.4.2 Evotec Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.4.3 Evotec Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Evotec Main Business Overview
11.4.5 Evotec Latest Developments
11.5 Sana Biotechnology
11.5.1 Sana Biotechnology Company Information
11.5.2 Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.5.3 Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sana Biotechnology Main Business Overview
11.5.5 Sana Biotechnology Latest Developments
11.6 Kadimastem
11.6.1 Kadimastem Company Information
11.6.2 Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.6.3 Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Kadimastem Main Business Overview
11.6.5 Kadimastem Latest Developments
11.7 iTolerance
11.7.1 iTolerance Company Information
11.7.2 iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.7.3 iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 iTolerance Main Business Overview
11.7.5 iTolerance Latest Developments
11.8 Seraxis
11.8.1 Seraxis Company Information
11.8.2 Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.8.3 Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Seraxis Main Business Overview
11.8.5 Seraxis Latest Developments
11.9 CRISPR Therapeutics
11.9.1 CRISPR Therapeutics Company Information
11.9.2 CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.9.3 CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 CRISPR Therapeutics Main Business Overview
11.9.5 CRISPR Therapeutics Latest Developments
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Information
11.10.2 Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.10.3 Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Novo Nordisk Main Business Overview
11.10.5 Novo Nordisk Latest Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Information
11.11.2 Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.11.3 Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Eli Lilly Main Business Overview
11.11.5 Eli Lilly Latest Developments
11.12 Sigilon Therapeutics
11.12.1 Sigilon Therapeutics Company Information
11.12.2 Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.12.3 Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sigilon Therapeutics Main Business Overview
11.12.5 Sigilon Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size (2021-2032)
2.1.2 Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Encapsulated iPSC-Derived Islet Cell Therapy by Country/Region (2021, 2025 & 2032)
2.2 Encapsulated iPSC-Derived Islet Cell Therapy Segment by Type
2.2.1 Macroencapsulation Device Therapy
2.2.2 Hydrogel Microencapsulation Therapy
2.2.3 Conformal Coating Encapsulation Therapy
2.2.4 Bioprinted Encapsulated Tissue Therapy
2.2.5 Local Immune Tolerance Matrix Therapy
2.2.6 Other Encapsulation Architectures
2.2.7 Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type
2.2.7.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.7.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
2.3 Encapsulated iPSC-Derived Islet Cell Therapy Segment by Cell Maturity Stage
2.3.1 Pancreatic Endoderm Cells
2.3.2 Immature Endocrine Progenitors
2.3.3 Beta Cell-Enriched Clusters
2.3.4 Islet-Like Endocrine Clusters
2.3.5 Mature Multihormonal Islet Cells
2.3.6 Other Maturity Stages
2.3.7 Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage
2.3.7.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Cell Maturity Stage (2021 VS 2025 VS 2032)
2.3.7.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Maturity Stage (2021-2026)
2.4 Encapsulated iPSC-Derived Islet Cell Therapy Segment by Immune Protection Strategy
2.4.1 Physical Immune Isolation
2.4.2 Local Immune Tolerance
2.4.3 Hypoimmune Gene Editing
2.4.4 Encapsulation Plus Gene Editing
2.4.5 Systemic Immunosuppression-Enabled
2.4.6 Other Immune Strategies
2.4.7 Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy
2.4.7.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Immune Protection Strategy (2021 VS 2025 VS 2032)
2.4.7.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2021-2026)
2.5 Encapsulated iPSC-Derived Islet Cell Therapy Segment by Development Stage
2.5.1 Discovery Research
2.5.2 Preclinical Development
2.5.3 IND-Enabling Development
2.5.4 Phase 1/2 Clinical Stage
2.5.5 Pivotal and Registration Stage
2.5.6 Discontinued or Legacy Assets
2.5.7 Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage
2.5.7.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Development Stage (2021 VS 2025 VS 2032)
2.5.7.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Development Stage (2021-2026)
2.6 Encapsulated iPSC-Derived Islet Cell Therapy Segment by Application
2.6.1 Type 1 Diabetes
2.6.2 Brittle Diabetes
2.6.3 Insulin-Dependent Type 2 Diabetes
2.6.4 Post-Pancreatectomy Diabetes
2.6.5 Islet Replacement Research
2.6.6 Other Diabetes Indications
2.6.7 Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application
2.6.7.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.6.7.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
3 ENCAPSULATED IPSC-DERIVED ISLET CELL THERAPY MARKET SIZE BY PLAYER
3.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Player
3.1.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026)
3.1.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ENCAPSULATED IPSC-DERIVED ISLET CELL THERAPY BY REGION
4.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026)
4.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
4.4 APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
4.5 Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026)
5.2 Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
5.3 Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026)
6.2 APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
6.3 APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026)
7.2 Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
7.3 Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy by Region (2021-2026)
8.2 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ENCAPSULATED IPSC-DERIVED ISLET CELL THERAPY MARKET FORECAST
10.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.1.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.1.2 Americas Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.1.3 APAC Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.1.4 Europe Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.1.5 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.2 Americas Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.2.2 Canada Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.2.3 Mexico Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.2.4 Brazil Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.3 APAC Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.3.1 China Encapsulated iPSC-Derived Islet Cell Therapy Market Forecast
10.3.2 Japan Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.3.3 Korea Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.3.4 Southeast Asia Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.3.5 India Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.3.6 Australia Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.4 Europe Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.4.2 France Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.4.3 UK Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.4.4 Italy Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.4.5 Russia Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.5 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.5.2 South Africa Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.5.3 Israel Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.5.4 Turkey Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
10.6 Global Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Type (2027-2032)
10.7 Global Encapsulated iPSC-Derived Islet Cell Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Encapsulated iPSC-Derived Islet Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Vertex Pharmaceuticals
11.1.1 Vertex Pharmaceuticals Company Information
11.1.2 Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.1.3 Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Vertex Pharmaceuticals Main Business Overview
11.1.5 Vertex Pharmaceuticals Latest Developments
11.2 Aspect Biosystems
11.2.1 Aspect Biosystems Company Information
11.2.2 Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.2.3 Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Aspect Biosystems Main Business Overview
11.2.5 Aspect Biosystems Latest Developments
11.3 Sernova
11.3.1 Sernova Company Information
11.3.2 Sernova Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.3.3 Sernova Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sernova Main Business Overview
11.3.5 Sernova Latest Developments
11.4 Evotec
11.4.1 Evotec Company Information
11.4.2 Evotec Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.4.3 Evotec Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Evotec Main Business Overview
11.4.5 Evotec Latest Developments
11.5 Sana Biotechnology
11.5.1 Sana Biotechnology Company Information
11.5.2 Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.5.3 Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sana Biotechnology Main Business Overview
11.5.5 Sana Biotechnology Latest Developments
11.6 Kadimastem
11.6.1 Kadimastem Company Information
11.6.2 Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.6.3 Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Kadimastem Main Business Overview
11.6.5 Kadimastem Latest Developments
11.7 iTolerance
11.7.1 iTolerance Company Information
11.7.2 iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.7.3 iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 iTolerance Main Business Overview
11.7.5 iTolerance Latest Developments
11.8 Seraxis
11.8.1 Seraxis Company Information
11.8.2 Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.8.3 Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Seraxis Main Business Overview
11.8.5 Seraxis Latest Developments
11.9 CRISPR Therapeutics
11.9.1 CRISPR Therapeutics Company Information
11.9.2 CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.9.3 CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 CRISPR Therapeutics Main Business Overview
11.9.5 CRISPR Therapeutics Latest Developments
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Information
11.10.2 Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.10.3 Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Novo Nordisk Main Business Overview
11.10.5 Novo Nordisk Latest Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Information
11.11.2 Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.11.3 Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Eli Lilly Main Business Overview
11.11.5 Eli Lilly Latest Developments
11.12 Sigilon Therapeutics
11.12.1 Sigilon Therapeutics Company Information
11.12.2 Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
11.12.3 Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sigilon Therapeutics Main Business Overview
11.12.5 Sigilon Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Encapsulated iPSC-Derived Islet Cell Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Macroencapsulation Device Therapy
Table 4. Major Players of Hydrogel Microencapsulation Therapy
Table 5. Major Players of Conformal Coating Encapsulation Therapy
Table 6. Major Players of Bioprinted Encapsulated Tissue Therapy
Table 7. Major Players of Local Immune Tolerance Matrix Therapy
Table 8. Major Players of Other Encapsulation Architectures
Table 9. Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 11. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Table 12. Major Players of Pancreatic Endoderm Cells
Table 13. Major Players of Immature Endocrine Progenitors
Table 14. Major Players of Beta Cell-Enriched Clusters
Table 15. Major Players of Islet-Like Endocrine Clusters
Table 16. Major Players of Mature Multihormonal Islet Cells
Table 17. Major Players of Other Maturity Stages
Table 18. Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Cell Maturity Stage (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage (2021-2026) & ($ millions)
Table 20. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Maturity Stage (2021-2026)
Table 21. Major Players of Physical Immune Isolation
Table 22. Major Players of Local Immune Tolerance
Table 23. Major Players of Hypoimmune Gene Editing
Table 24. Major Players of Encapsulation Plus Gene Editing
Table 25. Major Players of Systemic Immunosuppression-Enabled
Table 26. Major Players of Other Immune Strategies
Table 27. Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Immune Protection Strategy (2021 VS 2025 VS 2032) & ($ millions)
Table 28. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2021-2026) & ($ millions)
Table 29. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2021-2026)
Table 30. Major Players of Discovery Research
Table 31. Major Players of Preclinical Development
Table 32. Major Players of IND-Enabling Development
Table 33. Major Players of Phase 1/2 Clinical Stage
Table 34. Major Players of Pivotal and Registration Stage
Table 35. Major Players of Discontinued or Legacy Assets
Table 36. Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Development Stage (2021 VS 2025 VS 2032) & ($ millions)
Table 37. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage (2021-2026) & ($ millions)
Table 38. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Development Stage (2021-2026)
Table 39. Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 40. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 41. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Table 42. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026) & ($ millions)
Table 43. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Player (2021-2026)
Table 44. Encapsulated iPSC-Derived Islet Cell Therapy Key Players Head office and Products Offered
Table 45. Encapsulated iPSC-Derived Islet Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 46. New Products and Potential Entrants
Table 47. Mergers & Acquisitions, Expansion
Table 48. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 49. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Table 50. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 53. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Country (2021-2026)
Table 54. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 55. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Table 56. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 57. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Table 58. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 59. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Table 60. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 61. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 62. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 63. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Country (2021-2026)
Table 64. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 65. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 66. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 67. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 68. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 69. Key Market Drivers & Growth Opportunities of Encapsulated iPSC-Derived Islet Cell Therapy
Table 70. Key Market Challenges & Risks of Encapsulated iPSC-Derived Islet Cell Therapy
Table 71. Key Industry Trends of Encapsulated iPSC-Derived Islet Cell Therapy
Table 72. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 73. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 74. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 75. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 76. Vertex Pharmaceuticals Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 77. Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 78. Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Vertex Pharmaceuticals Main Business
Table 80. Vertex Pharmaceuticals Latest Developments
Table 81. Aspect Biosystems Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 82. Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 83. Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Aspect Biosystems Main Business
Table 85. Aspect Biosystems Latest Developments
Table 86. Sernova Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 87. Sernova Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 88. Sernova Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Sernova Main Business
Table 90. Sernova Latest Developments
Table 91. Evotec Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 92. Evotec Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 93. Evotec Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Evotec Main Business
Table 95. Evotec Latest Developments
Table 96. Sana Biotechnology Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 97. Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 98. Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Sana Biotechnology Main Business
Table 100. Sana Biotechnology Latest Developments
Table 101. Kadimastem Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 102. Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 103. Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Kadimastem Main Business
Table 105. Kadimastem Latest Developments
Table 106. iTolerance Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 107. iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 108. iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. iTolerance Main Business
Table 110. iTolerance Latest Developments
Table 111. Seraxis Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 112. Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 113. Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Seraxis Main Business
Table 115. Seraxis Latest Developments
Table 116. CRISPR Therapeutics Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 117. CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 118. CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. CRISPR Therapeutics Main Business
Table 120. CRISPR Therapeutics Latest Developments
Table 121. Novo Nordisk Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 122. Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 123. Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Novo Nordisk Main Business
Table 125. Novo Nordisk Latest Developments
Table 126. Eli Lilly Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 127. Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 128. Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Eli Lilly Main Business
Table 130. Eli Lilly Latest Developments
Table 131. Sigilon Therapeutics Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 132. Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 133. Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Sigilon Therapeutics Main Business
Table 135. Sigilon Therapeutics Latest Developments
Table 1. Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Encapsulated iPSC-Derived Islet Cell Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Macroencapsulation Device Therapy
Table 4. Major Players of Hydrogel Microencapsulation Therapy
Table 5. Major Players of Conformal Coating Encapsulation Therapy
Table 6. Major Players of Bioprinted Encapsulated Tissue Therapy
Table 7. Major Players of Local Immune Tolerance Matrix Therapy
Table 8. Major Players of Other Encapsulation Architectures
Table 9. Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 11. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Table 12. Major Players of Pancreatic Endoderm Cells
Table 13. Major Players of Immature Endocrine Progenitors
Table 14. Major Players of Beta Cell-Enriched Clusters
Table 15. Major Players of Islet-Like Endocrine Clusters
Table 16. Major Players of Mature Multihormonal Islet Cells
Table 17. Major Players of Other Maturity Stages
Table 18. Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Cell Maturity Stage (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage (2021-2026) & ($ millions)
Table 20. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Maturity Stage (2021-2026)
Table 21. Major Players of Physical Immune Isolation
Table 22. Major Players of Local Immune Tolerance
Table 23. Major Players of Hypoimmune Gene Editing
Table 24. Major Players of Encapsulation Plus Gene Editing
Table 25. Major Players of Systemic Immunosuppression-Enabled
Table 26. Major Players of Other Immune Strategies
Table 27. Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Immune Protection Strategy (2021 VS 2025 VS 2032) & ($ millions)
Table 28. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy (2021-2026) & ($ millions)
Table 29. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy (2021-2026)
Table 30. Major Players of Discovery Research
Table 31. Major Players of Preclinical Development
Table 32. Major Players of IND-Enabling Development
Table 33. Major Players of Phase 1/2 Clinical Stage
Table 34. Major Players of Pivotal and Registration Stage
Table 35. Major Players of Discontinued or Legacy Assets
Table 36. Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Development Stage (2021 VS 2025 VS 2032) & ($ millions)
Table 37. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage (2021-2026) & ($ millions)
Table 38. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Development Stage (2021-2026)
Table 39. Encapsulated iPSC-Derived Islet Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 40. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 41. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Table 42. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Player (2021-2026) & ($ millions)
Table 43. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Player (2021-2026)
Table 44. Encapsulated iPSC-Derived Islet Cell Therapy Key Players Head office and Products Offered
Table 45. Encapsulated iPSC-Derived Islet Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 46. New Products and Potential Entrants
Table 47. Mergers & Acquisitions, Expansion
Table 48. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 49. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Table 50. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 53. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Country (2021-2026)
Table 54. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 55. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Table 56. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 57. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Table 58. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 59. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Table 60. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 61. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 62. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country (2021-2026) & ($ millions)
Table 63. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Country (2021-2026)
Table 64. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 65. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 66. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region (2021-2026) & ($ millions)
Table 67. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type (2021-2026) & ($ millions)
Table 68. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2026) & ($ millions)
Table 69. Key Market Drivers & Growth Opportunities of Encapsulated iPSC-Derived Islet Cell Therapy
Table 70. Key Market Challenges & Risks of Encapsulated iPSC-Derived Islet Cell Therapy
Table 71. Key Industry Trends of Encapsulated iPSC-Derived Islet Cell Therapy
Table 72. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 73. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 74. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 75. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 76. Vertex Pharmaceuticals Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 77. Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 78. Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Vertex Pharmaceuticals Main Business
Table 80. Vertex Pharmaceuticals Latest Developments
Table 81. Aspect Biosystems Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 82. Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 83. Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Aspect Biosystems Main Business
Table 85. Aspect Biosystems Latest Developments
Table 86. Sernova Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 87. Sernova Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 88. Sernova Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Sernova Main Business
Table 90. Sernova Latest Developments
Table 91. Evotec Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 92. Evotec Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 93. Evotec Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Evotec Main Business
Table 95. Evotec Latest Developments
Table 96. Sana Biotechnology Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 97. Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 98. Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Sana Biotechnology Main Business
Table 100. Sana Biotechnology Latest Developments
Table 101. Kadimastem Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 102. Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 103. Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Kadimastem Main Business
Table 105. Kadimastem Latest Developments
Table 106. iTolerance Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 107. iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 108. iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. iTolerance Main Business
Table 110. iTolerance Latest Developments
Table 111. Seraxis Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 112. Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 113. Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Seraxis Main Business
Table 115. Seraxis Latest Developments
Table 116. CRISPR Therapeutics Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 117. CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 118. CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. CRISPR Therapeutics Main Business
Table 120. CRISPR Therapeutics Latest Developments
Table 121. Novo Nordisk Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 122. Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 123. Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Novo Nordisk Main Business
Table 125. Novo Nordisk Latest Developments
Table 126. Eli Lilly Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 127. Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 128. Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Eli Lilly Main Business
Table 130. Eli Lilly Latest Developments
Table 131. Sigilon Therapeutics Details, Company Type, Encapsulated iPSC-Derived Islet Cell Therapy Area Served and Its Competitors
Table 132. Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product Offered
Table 133. Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Sigilon Therapeutics Main Business
Table 135. Sigilon Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Encapsulated iPSC-Derived Islet Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Encapsulated iPSC-Derived Islet Cell Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Encapsulated iPSC-Derived Islet Cell Therapy Sales Market Share by Country/Region (2025)
Figure 8. Encapsulated iPSC-Derived Islet Cell Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type in 2025
Figure 10. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Maturity Stage in 2025
Figure 11. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy in 2025
Figure 12. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Development Stage in 2025
Figure 13. Encapsulated iPSC-Derived Islet Cell Therapy in Type 1 Diabetes
Figure 14. Global Encapsulated iPSC-Derived Islet Cell Therapy Market: Type 1 Diabetes (2021-2026) & ($ millions)
Figure 15. Encapsulated iPSC-Derived Islet Cell Therapy in Brittle Diabetes
Figure 16. Global Encapsulated iPSC-Derived Islet Cell Therapy Market: Brittle Diabetes (2021-2026) & ($ millions)
Figure 17. Encapsulated iPSC-Derived Islet Cell Therapy in Insulin-Dependent Type 2 Diabetes
Figure 18. Global Encapsulated iPSC-Derived Islet Cell Therapy Market: Insulin-Dependent Type 2 Diabetes (2021-2026) & ($ millions)
Figure 19. Encapsulated iPSC-Derived Islet Cell Therapy in Post-Pancreatectomy Diabetes
Figure 20. Global Encapsulated iPSC-Derived Islet Cell Therapy Market: Post-Pancreatectomy Diabetes (2021-2026) & ($ millions)
Figure 21. Encapsulated iPSC-Derived Islet Cell Therapy in Islet Replacement Research
Figure 22. Global Encapsulated iPSC-Derived Islet Cell Therapy Market: Islet Replacement Research (2021-2026) & ($ millions)
Figure 23. Encapsulated iPSC-Derived Islet Cell Therapy in Other Diabetes Indications
Figure 24. Global Encapsulated iPSC-Derived Islet Cell Therapy Market: Other Diabetes Indications (2021-2026) & ($ millions)
Figure 25. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application in 2025
Figure 26. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Player in 2025
Figure 27. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 28. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 29. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 30. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 31. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 32. Americas Encapsulated iPSC-Derived Islet Cell Therapy Value Market Share by Country in 2025
Figure 33. United States Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Canada Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. Mexico Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Brazil Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Region in 2025
Figure 38. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 39. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 40. China Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. Japan Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. South Korea Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Southeast Asia Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 44. India Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. Australia Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 46. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Country in 2025
Figure 47. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 48. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 49. Germany Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. France Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. UK Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 52. Italy Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. Russia Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 54. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 55. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 56. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 57. Egypt Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 58. South Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 59. Israel Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 60. Turkey Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 61. GCC Countries Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 62. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 63. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 64. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 65. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 66. United States Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 67. Canada Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 68. Mexico Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 69. Brazil Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 70. China Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 71. Japan Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 72. Korea Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 73. Southeast Asia Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 74. India Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 75. Australia Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 76. Germany Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 77. France Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 78. UK Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 79. Italy Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 80. Russia Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 81. Egypt Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 82. South Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 83. Israel Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 84. Turkey Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 85. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 86. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 87. GCC Countries Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 1. Encapsulated iPSC-Derived Islet Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Encapsulated iPSC-Derived Islet Cell Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Encapsulated iPSC-Derived Islet Cell Therapy Sales Market Share by Country/Region (2025)
Figure 8. Encapsulated iPSC-Derived Islet Cell Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type in 2025
Figure 10. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Cell Maturity Stage in 2025
Figure 11. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Immune Protection Strategy in 2025
Figure 12. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Development Stage in 2025
Figure 13. Encapsulated iPSC-Derived Islet Cell Therapy in Type 1 Diabetes
Figure 14. Global Encapsulated iPSC-Derived Islet Cell Therapy Market: Type 1 Diabetes (2021-2026) & ($ millions)
Figure 15. Encapsulated iPSC-Derived Islet Cell Therapy in Brittle Diabetes
Figure 16. Global Encapsulated iPSC-Derived Islet Cell Therapy Market: Brittle Diabetes (2021-2026) & ($ millions)
Figure 17. Encapsulated iPSC-Derived Islet Cell Therapy in Insulin-Dependent Type 2 Diabetes
Figure 18. Global Encapsulated iPSC-Derived Islet Cell Therapy Market: Insulin-Dependent Type 2 Diabetes (2021-2026) & ($ millions)
Figure 19. Encapsulated iPSC-Derived Islet Cell Therapy in Post-Pancreatectomy Diabetes
Figure 20. Global Encapsulated iPSC-Derived Islet Cell Therapy Market: Post-Pancreatectomy Diabetes (2021-2026) & ($ millions)
Figure 21. Encapsulated iPSC-Derived Islet Cell Therapy in Islet Replacement Research
Figure 22. Global Encapsulated iPSC-Derived Islet Cell Therapy Market: Islet Replacement Research (2021-2026) & ($ millions)
Figure 23. Encapsulated iPSC-Derived Islet Cell Therapy in Other Diabetes Indications
Figure 24. Global Encapsulated iPSC-Derived Islet Cell Therapy Market: Other Diabetes Indications (2021-2026) & ($ millions)
Figure 25. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application in 2025
Figure 26. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue Market Share by Player in 2025
Figure 27. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 28. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 29. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 30. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 31. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2021-2026 ($ millions)
Figure 32. Americas Encapsulated iPSC-Derived Islet Cell Therapy Value Market Share by Country in 2025
Figure 33. United States Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Canada Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. Mexico Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Brazil Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Region in 2025
Figure 38. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 39. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 40. China Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. Japan Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. South Korea Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Southeast Asia Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 44. India Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. Australia Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 46. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Country in 2025
Figure 47. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 48. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 49. Germany Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. France Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. UK Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 52. Italy Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. Russia Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 54. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Region (2021-2026)
Figure 55. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Type (2021-2026)
Figure 56. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share by Application (2021-2026)
Figure 57. Egypt Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 58. South Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 59. Israel Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 60. Turkey Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 61. GCC Countries Encapsulated iPSC-Derived Islet Cell Therapy Market Size Growth 2021-2026 ($ millions)
Figure 62. Americas Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 63. APAC Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 64. Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 65. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 66. United States Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 67. Canada Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 68. Mexico Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 69. Brazil Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 70. China Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 71. Japan Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 72. Korea Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 73. Southeast Asia Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 74. India Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 75. Australia Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 76. Germany Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 77. France Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 78. UK Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 79. Italy Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 80. Russia Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 81. Egypt Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 82. South Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 83. Israel Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 84. Turkey Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
Figure 85. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 86. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 87. GCC Countries Encapsulated iPSC-Derived Islet Cell Therapy Market Size 2027-2032 ($ millions)
